One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes.
Vatier C, Arnaud L, Prieur X, Guyomarch B, Le May C, Bigot E, Pichelin M, Daguenel A, Vantyghem MC, Gautier JF, Vigouroux C, Cariou B.
Vatier C, et al. Among authors: gautier jf.
Diabetes Metab. 2017 Jun;43(3):275-279. doi: 10.1016/j.diabet.2016.08.004. Epub 2016 Sep 28.
Diabetes Metab. 2017.
PMID: 27692500
No abstract available.